Trials / Sponsors / Kai Lin Xu; Jun Nian Zheng
Kai Lin Xu; Jun Nian Zheng
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | 2021-03-19 |
| Unknown | CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia | Phase 1 | 2019-12-10 |
| Unknown | CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies Recurrent or Refractory B Cell Malignancy | Phase 1 / Phase 2 | 2016-06-01 |
| Unknown | Humanized CAR-T Therapy for Treatment of B Cell Malignancy Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | 2016-05-01 |